The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Around 70% of people aged 50-plus receiving HIV care in Latin America in 2015 had an NCD, compared to 32% in the year 2000.
Studies have revealed that women living with HIV in Latin America and the Caribbean are at a greater risk of harm. Misinformation around their contraceptive options and sexual and reproductive health rights has resulted in high levels of unwanted sterilization and abortion in the region.
There were no significant differences in adherence and viral suppression rates between people in relationships and those who are single in Brazil, but the type of regime and pill quantities predict better outcomes.
The number of people living with HIV experiencing more than one non-communicable disease (NCD) increased as they got older, with metabolic diseases being the biggest contributor.
Results from Latin America’s first PrEP demonstration project reveal that it is both feasible and effective as an HIV prevention method in the region. Will Brazil’s example pave the way for the rest of the region?
New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions.
A new low-cost, low-tech method for predicting an adult’s risk of developing tuberculosis (TB) could represent a major step forward for TB prevention.
Concerns have been raised about the shortage of antiretroviral drugs available for people living with HIV in Venezuela, which is in the midst of a mounting health crisis.
Peru is the latest country to approve the use of the antiretroviral drug, Truvada, as pre-exposure prohpylaxis (PrEP) to prevent HIV among people at a high risk of infection.